Medical Journal. The increase in the cost of R&D and its fruits will force a new industry-financier relationship. The Tufts Center is also aiming for the continuation of oncology as a leading area for trials.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
